Login / Signup

Timeliness of cancer care in a regional Victorian health service: A comparison of high-volume (Lung) and low-volume (oesophagogastric) tumour streams.

Mwila KabweAmanda RobinsonYachna ShethiaCarol ParkerRobert BlumIlana SoloMichael Leach
Published in: Cancer reports (Hoboken, N.J.) (2020)
In the low-volume OG cancer stream, patients had longer wait times from referral to an MDM, where treatment decisions occur, but shorter time to commencement of first treatment. Conversely in the high-volume lung cancer group, there was delayed initiation of first treatment following presentation at MDM. There is need to explore ways to fast-track MDM presentation and commencement of therapy among people diagnosed with low-volume and high-volume cancers, respectively.
Keyphrases
  • end stage renal disease
  • stem cells
  • squamous cell carcinoma
  • newly diagnosed
  • combination therapy
  • ejection fraction
  • papillary thyroid
  • case report
  • peritoneal dialysis
  • cell therapy
  • squamous cell